CVS Health 的主要股东 Glenview Capital 计划在最近的困境和 22% 的份额下降中与高管会面，提出一项价值提升计划。 Glenview Capital, CVS Health's major shareholder, plans to meet execs to propose a value enhancement plan amid recent struggles and a 22% share decline.
Glenview Capital, CVS Health的主要股东,打算与执行官会晤,提出旨在提高公司价值的计划,可能预示一场积极运动。 Glenview Capital, a major shareholder of CVS Health, intends to meet with executives to propose a plan aimed at enhancing the company's value, potentially signaling an activist campaign. CVS最近面临22%的股率下降和连续四分之三的下调,主要由于零售药店和保险行业的挑战,CVS最近挣扎不已。 CVS has struggled recently, facing a 22% share decline and three consecutive quarters of lowered guidance, largely due to challenges in its retail pharmacy and insurance sectors. 该公司计划削减20亿美元的开支,作为解决这些问题的一部分。 The company plans to cut $2 billion in expenses as part of its response to these issues.